Why Is HIMS & HERS HEALTH I A (HIMS) Stock Down Today?

Hims & Hers Health Inc (HIMS) fell 14.73% to $25.00 in morning trading as the U.S. Federal Trade Commission filed a lawsuit against the telehealth company. The suit alleges the firm shared sensitive health data with Meta and Snap while misleading users about billing and subscription cancellation practices. The stock has declined 23.5% over the last eight sessions as the legal action intensifies scrutiny of its data and billing practices.

What Happened

The U.S. Federal Trade Commission filed a federal lawsuit against Hims & Hers, accusing the company of sharing user health data with online advertisers and deceiving customers about billing and subscription cancellation procedures. The lawsuit, announced Wednesday, alleges the telehealth provider violated consumer privacy protections by transferring sensitive health information to third-party platforms such as Meta and Snap. The company responded by stating the lawsuit disregards evidence it provided to the FTC during a nearly three-year investigation. Hims & Hers expressed confidence in its position and pledged to defend itself against the allegations.

What The Data Shows

The stock has traded within a 52-week range of $13.74 to $70.43 and currently has a market capitalization of $7.0 billion. The company remains unprofitable with a trailing twelve-month earnings per share of -0.06 and a net margin of -0.6%. Revenue grew 32.8% in the trailing twelve months, but the stock’s beta of 2.34 indicates high volatility. Over the last 36 hours, 13 unusual options prints were recorded, with put premiums outpacing call premiums. The largest single options trade involved $2.1 million in premium. In the last 90 days, insiders sold $3.9 million in shares, including multiple sales by CFO Okupe Oluyemi.

What To Watch

The company has not scheduled earnings in the immediate future, but coverage breadth is growing. Retail traders on r/wallstreetbets and social media have mentioned the stock, and options activity remains elevated. The outcome of the FTC lawsuit will be a key factor in shaping investor sentiment.

Why is HIMS stock down today?

HIMS & HERS HEALTH I A (HIMS) is down -14.73% in the latest session. Our newswire has captured 11 stories on HIMS across 10 sources in the last 36 hours, with AI sentiment reading bearish (avg 37/100). The most recent driver: "Hims & Hers stock sinks after FTC sues over health data sharing and billing" (Quartz).

Is HIMS a buy right now?

Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of HIMS coverage reads 37/100 over 11 stories; treat it as a research signal and do your own diligence.

How fast does this page update?

The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.